Table 1 Changes in serum biochemical parameters

From: Advanced glycation end products suppress lysyl oxidase and induce bone collagen degradation in a rat model of renal osteodystrophy

 

Adenine-administered period

Parameters

2 weeks (n=7)

4 weeks (n=7)

6 weeks (n=7)

Urea nitrogen (mg/dl)

 Adenine

124.2±23.8a

213.9±45.3a

218.6±20.6a

 Control

23.6±3.6

26.8±5.1

27.2±5.4

Creatinine (mg/dl)

 Adenine

1.3±0.3a

2.0±0.3a

2.1±0.3a

 Control

0.3±0.1

0.3±0.1

0.3±0.1

Calcium (mg/dl)

 Adenine

11.3±0.8

9.1±1.6a

9.2±1.6b

 Control

11.2±0.5

12.0±1.0

11.8±0.9

Inorganic phosphorus (mg/dl)

 Adenine

14.8±2.6b

20.1±6.7a

16.1±2.6b

 Control

12.2±1.6

11.5±3.0

12.1±3.5

Intact PTH (pg/ml)

 Adenine

868±641b

5065±1233a

5726±2352a

 Control

223±158

86±41

114±97

1,25(OH) 2 D 3 (pg/ml)

 Adenine

41.1±30.8b

3.9±1.4a

8.7±4.7a

 Control

212.5±69.5

219.2±62.9

141.1±40.7

BALP (U/L)

 Adenine

25.4±14.6

26.5±12.6b

26.8±19.8

 Control

22.3±5.8

16.7±7.5

21.4±5.9

TRACP-5b (mU/dl)

 Adenine

1293±881b

177±189a

106±83a

 Control

2364±881

2438±881

2424±868

  1. Abbreviations: BALP, serum bone alkaline phosphatase; TRACP-5b, serum tartrate-resistant acid phosphatase 5b derived from osteoclasts.
  2. Data are shown as means±s.d. Significant differences were identified using the Mann–Whitney’s U-test.
  3. aP<0.01 vs control.
  4. bP<0.05.